Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Teresa S. Latham · Sankore

Teresa S. Latham

ORCID, self-asserted

ORCID 0000-0002-4473-5821

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it.

Publications

22

Citations

145

h-index

6

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

4

Publications

4 works in the graph, newest first.

Hydroxyurea for Children and Adults with Hemoglobin SC Disease
2024NEJM EvidenceJournalOpen access19 citations10.1056/evidoa2400402
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT , a randomised clinical trial of hydroxyurea in HbSC disease in sub‐Saharan Africa
2024British Journal of HaematologyJournalOpen access5 citations10.1111/bjh.19832
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease
2023TrialsJournalOpen access5 citations10.1186/s13063-023-07649-7
P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE
2022HemaSphereJournalOpen access0 citations10.1097/01.hs9.0000873080.46800.92